510(k) K770459

URIC ACID PROCEDURE, TEKPOINT DIRECT by Icn Pharmaceuticals, Inc. — Product Code CDH

K770459 is an FDA 510(k) premarket notification submitted by Icn Pharmaceuticals, Inc. for the device "URIC ACID PROCEDURE, TEKPOINT DIRECT". The FDA issued a decision of Substantially Equivalent on Apr 29, 1977. The device falls under product code CDH (Acid, Uric, Phosphotungstate Reduction), a Class I device regulated under 21 CFR 862.1775. Icn Pharmaceuticals, Inc. has 29 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Apr 29, 1977
Date Received
Mar 8, 1977
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Acid, Uric, Phosphotungstate Reduction
Device Class
Class I
Regulation Number
862.1775
Review Panel
CH
Submission Type
510(k) Exempt

Need the full FDA record for Icn Pharmaceuticals, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K770459. Report a data issue: hello@regdatalab.com.